0001209191-20-031023.txt : 20200520 0001209191-20-031023.hdr.sgml : 20200520 20200520184527 ACCESSION NUMBER: 0001209191-20-031023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200518 FILED AS OF DATE: 20200520 DATE AS OF CHANGE: 20200520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDBERG MURRAY A CENTRAL INDEX KEY: 0001226435 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36152 FILM NUMBER: 20899421 MAIL ADDRESS: STREET 1: 2030 MAIN STREET, SUITE 1500 CITY: IRVINE STATE: CA ZIP: 92614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001337553 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203109565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4301 EMPEROR BOULEVARD STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: (919) 237-5300 MAIL ADDRESS: STREET 1: 4301 EMPEROR BOULEVARD STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-18 0 0001337553 AERIE PHARMACEUTICALS INC AERI 0001226435 GOLDBERG MURRAY A C/O AERIE PHARMACEUTICALS, INC. 4301 EMPEROR BLVD., SUITE 400 DURHAM NC 27703 1 0 0 0 Common Stock 2020-05-18 4 M 0 28000 3.15 A 36050 D Stock Option (right to buy) 3.15 2020-05-18 4 M 0 28000 0.00 D 2023-09-12 Common Stock 28000 0 D This option is fully vested and exercisable. /s/ John LaRocca, Attorney-in-Fact for Murray A. Goldberg 2020-05-20